These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 29773600

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission.
    Xie LH, Biondo M, Busfield SJ, Arruda A, Yang X, Vairo G, Minden MD.
    Blood Cancer J; 2017 Jun 02; 7(6):e567. PubMed ID: 28574487
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. CD123: A Novel Biomarker for Diagnosis and Treatment of Leukemia.
    Shi M, Su RJ, Parmar KP, Chaudhry R, Sun K, Rao J, Chen M.
    Cardiovasc Hematol Disord Drug Targets; 2019 Jun 02; 19(3):195-204. PubMed ID: 31244444
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.
    Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, Luger SM, Phillips GL.
    Leukemia; 2000 Oct 02; 14(10):1777-84. PubMed ID: 11021753
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.
    Jin L, Lee EM, Ramshaw HS, Busfield SJ, Peoppl AG, Wilkinson L, Guthridge MA, Thomas D, Barry EF, Boyd A, Gearing DP, Vairo G, Lopez AF, Dick JE, Lock RB.
    Cell Stem Cell; 2009 Jul 02; 5(1):31-42. PubMed ID: 19570512
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Targeting CD123 in AML.
    Lane AA.
    Clin Lymphoma Myeloma Leuk; 2020 Sep 02; 20 Suppl 1():S67-S68. PubMed ID: 32862874
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia.
    Aldoss I, Clark M, Song JY, Pullarkat V.
    Hum Vaccin Immunother; 2020 Oct 02; 16(10):2341-2348. PubMed ID: 32692611
    [Abstract] [Full Text] [Related]

  • 38. Marked upregulation of Survivin and Aurora-B kinase is associated with disease progression in the myelodysplastic syndromes.
    Yoshida A, Zokumasu K, Wano Y, Yamauchi T, Imamura S, Takagi K, Kishi S, Urasaki Y, Tohyama K, Ueda T.
    Haematologica; 2012 Sep 02; 97(9):1372-9. PubMed ID: 22419576
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.